Shengkai Geng

A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients

Yipeng Fu, Kejin Wu, Shengkai Geng, 2022, Frontiers in Immunology.

Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling

Hong Wang, W. Jin, Hongwei Zhang, 2022, Human Cell.

Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer

Shao-mei Fu, Shengkai Geng, Hong-wei Zhang, 2022, BMC cancer.

MORC4 is a novel breast cancer oncogene regulated by miR‐193b‐3p

Zi'ang Yang, Guangfu Hu, Q. Zhuang, 2018, Journal of cellular biochemistry.

Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy

Hong-wei Zhang, Shi-Hong Ma, Shao-mei Fu, 2021, BMC cancer.

Neutrophil to lymphocyte ratio is a prognostic factor for disease free survival in patients with breast cancer underwent curative resection

Hong-wei Zhang, Shao-mei Fu, Shengkai Geng, 2018, Medicine.